Abstract
Objectives:This study examined how physicians perceive pharmaceutical companies’ medication assistance programs (MAPs).Methods:The study was conducted using a survey of 373 primary care physicians from four southern states; they were surveyed within the formative evaluation phase of a larger study (MI-Plus). Respondents were queried about use and usefulness of MAPs for patients who cannot afford drugs, and barriers to using them. Bivariate associations between physician-level variables (patients without drug coverage) and usefulness and barriers to using MAPs were assessed using Chi square tests. Independence of associations was assessed using multiple logistic regressions.Results:Of the 364 (97.6%) respondents who used MAPs, 70% used them regularly, the rest occasionally; 63% found MAPs very useful in caring for patients who could not afford drugs. About 89% reported one or more barriers to using MAPs; 47% saw “inability of patients to apply directly;” and 57% saw “enrollment process being time-consuming for staff” as barriers. Compared to physicians with fewer elderly patients without drug coverage, those with more of these patients were less likely to find MAPs very useful; less likely to report no barriers to using MAPs; and more likely to see “low income thresholds” and “inability of patients to apply directly” as barriers.Conclusion:While MAPs are considered useful in caring for patients in need of assistance, there are many barriers to their use. Pharmaceutical companies should address these barriers. Limitations include a low response rate (about 10%).
This content is limited to qualifying members.
If you have an existing account please login now to access this article or view purchase options.
Create a free account, then purchase this article to download or access it online for 24 hours.
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
References
References1.Berenson A. A cancer drug shows promise, at a price that many can’t pay. NY Times 2006;A1:C2.2.Chisholm MA, DiPiro JT. Pharmaceutical manufacturer assistance programs. Arch Intern Med 2002;162:780–784.ChisholmMA]]DiPiroJTPharmaceutical manufacturer assistance programs.Arch Intern Med2002162780-7843.Hartsfield JA IV. Pharmaceutical companies meet the needs of the poor and uninsured: an important element in the healthcare safety net. N C Med J 2005;66:144–146.HartsfieldJAIVPharmaceutical companies meet the needs of the poor and uninsured: an important element in the healthcare safety net.N C Med J200566144-1464.Dent LA, Stratton TP, Cochran GA. Establishing an on-site pharmacy in a community health center to help indigent patients access medications and to improve care. J Am Pharm Assoc (Wash) 2002;42:497–507.DentLA]]StrattonTP]]CochranGAEstablishing an on-site pharmacy in a community health center to help indigent patients access medications and to improve care.J Am Pharm Assoc (Wash)200242497-5075.Schoen MD, DiDomenico RJ, Connor SE, et al. Impact of the cost of prescription drugs on clinical outcomes in indigent patients with heart disease. Pharmacotherapy 2001;21:1455–1463.SchoenMD]]DiDomenicoRJ]]ConnorSE&etal;Impact of the cost of prescription drugs on clinical outcomes in indigent patients with heart disease.Pharmacotherapy2001211455-14636.Decane BE, Chapman J. Program for procurement of drugs for indigent patients. Am J Hosp Pharm 1994;51:669–671.DecaneBE]]ChapmanJProgram for procurement of drugs for indigent patients.Am J Hosp Pharm199451669-6717.Harmon GN, Lefante J, Roy W, et al. Outpatient medication assistance program in a rural setting. Am J Health Syst Pharm 2004;61:603–607.HarmonGN]]LefanteJ]]RoyW&etal;Outpatient medication assistance program in a rural setting.Am J Health Syst Pharm200461603-6078.Hotchkiss BD, Pearson C, Lisitano R. Pharmacy coordination of an indigent care program in a psychiatric facility. Am J Health Syst Pharm 1998;55:1293–1296.HotchkissBD]]PearsonC]]LisitanoRPharmacy coordination of an indigent care program in a psychiatric facility.Am J Health Syst Pharm1998551293-12969.Viale PH, Mister S. Utilization of medication-assistance programs for medically uninsured patients: one public teaching hospital’s experience. Clin J Oncol Nurs 2001;5:247–252.VialePH]]MisterSUtilization of medication-assistance programs for medically uninsured patients: one public teaching hospital’s experience.Clin J Oncol Nurs20015247-25210.Mounts VL, Ringenberg DG, Rhees K, et al. Implementation of a patient medication assistance program in a community pharmacy setting. J Am Pharm Assoc (2003) 2005;45:76–81.MountsVL]]RingenbergDG]]RheesK&etal;Implementation of a patient medication assistance program in a community pharmacy setting.J Am Pharm Assoc (2003)20054576-8111.Williams K. Accessing patient assistance programs to meet clients’ medication needs. J Am Acad Nurse Pract 2000;12:233–235.WilliamsKAccessing patient assistance programs to meet clients’ medication needs.J Am Acad Nurse Pract200012233-23512.Tseng CW, Brook RH, Keeler E, et al. Impact of an annual dollar limit or “cap” on prescription drug benefits for Medicare patients. JAMA 2003;290:222–227.TsengCW]]BrookRH]]KeelerE&etal;Impact of an annual dollar limit or “cap” on prescription drug benefits for Medicare patients.JAMA2003290222-22713.Tseng CW, Brook RH, Keeler E, et al. Cost-lowering strategies used by medicare beneficiaries who exceed drug benefit caps and have a gap in drug coverage. JAMA 2004;292:952–960.TsengCW]]BrookRH]]KeelerE&etal;Cost-lowering strategies used by medicare beneficiaries who exceed drug benefit caps and have a gap in drug coverage.JAMA2004292952-96014.Hikmet N, Chen SK. An investigation into low mail survey response rates of information technology users in health care organizations. Int J Med Inform 2003;72:29–34.HikmetN]]ChenSKAn investigation into low mail survey response rates of information technology users in health care organizations.Int J Med Inform20037229-3415.Madden JM, Graves AJ, Zhang F, et al. Cost-related medication nonadherence and spending on basic needs following implementation of Medicare Part D. JAMA 2008;299:1922–1928.MaddenJM]]GravesAJ]]ZhangF&etal;Cost-related medication nonadherence and spending on basic needs following implementation of Medicare Part D.JAMA20082991922-192816.Kirking DM, Lee JA, Ellis JJ, et al. Patient-reported underuse of prescription medications: a comparison of nine surveys. Med Care Res Rev 2006;63:427–446.KirkingDM]]LeeJA]]EllisJJ&etal;Patient-reported underuse of prescription medications: a comparison of nine surveys.Med Care Res Rev200663427-44617.Carroll NV. Pharmaceutical patient assistance programs: don’t look a gift horse in the mouth or there’s no such thing as a free lunch. J Manag Care Pharm 2007;13:614–616.CarrollNVPharmaceutical patient assistance programs: don’t look a gift horse in the mouth or there’s no such thing as a free lunch.J Manag Care Pharm200713614-616
